MAY 19, 2020 1:45 PM EDT | APAC MAY 20, 2020 4:45 PM CST

Tumor Signaling 360 Panel: A 360° View of Altered Signaling Pathways in Cancer

Speaker

Abstract

Targeted therapies for cancer are increasingly being developed as an alternative for, and in addition to, immunotherapy. Altered tumor signaling can be exploited to single-out cancer cells for destruction while leaving normal cells intact. However, as we continue to learn, a therapeutic strategy that treats the biology of the tumor by itself in a vacuum without the context of the immune response and the surrounding microenvironment can lead to reduced efficacy. The new nCounter Tumor Signaling 360 gene expression panel homes in on signaling pathways involved in the sustained growth and maintenance of tumor cells while providing a holistic view of the immune response and microenvironment that can be complicit in the development and progression of cancer. Using the foundation of the PanCancer IO 360 and Breast Cancer 360 panels as a model, the Tumor Signaling 360 panel was designed to include 770 genes across 40+ pathways integral for tumor biology, immune evasion, and microenvironment remodeling. The panel offers the same direct, digital detection benefits of other NanoString gene expression panels and includes the 18-gene Tumor Inflammation Signature (TIS) as well as 14 immune cell type signatures for profiling the peripheral immune response.


Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
APR 28, 2022 8:00 AM PDT
APR 28, 2022 8:00 AM PDT
Date: April 28, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Human pluripotent stem cells (PSCs) and their derivatives hold great potentials in...
MAY 19, 2022 8:00 AM PDT
MAY 19, 2022 8:00 AM PDT
Date: May 19, 2022 Time: 8:00am (PDT), 11:00pm (EDT), 5:00pm (CEST) Mass spectrometry (MS)-based proteomic technologies are increasingly applied in a clinical context for disease classific...
NOV 30, 2021 11:00 AM PST
C.E. CREDITS
NOV 30, 2021 11:00 AM PST
Date: November 30, 2021 Time: 11:00am (PDT), 2:00pm (EDT) In the recent years, measurable residual disease (MRD) assessment on multiple myeloma patients has gained increasing relevance. After...
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
Loading Comments...
Show Resources